Log in
Enquire now
Nucleai

Nucleai

Nucleai is an AI-powered Tumor Micro Environment modeling founded in 2018 by Avi Veidman, Eliron Amir and Lotan Chorev.

OverviewStructured DataIssuesContributors

Contents

nucleai.ai
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Location
Chicago
Chicago
0
Tel Aviv
Tel Aviv
0
B2X
B2B
B2B
CEO
Avi Veidman
Avi Veidman
0
Founder
Avi Veidman
Avi Veidman
0
‌
Lotan Chorev
0
Eliron Amir
Eliron Amir
0
Pitchbook URL
pitchbook.com/profiles...226468-54
Legal Name
Nucleai Inc.0
Number of Employees (Ranges)
51 – 2000
Email Address
Full Address
4 Ein Zeitim St, Tel Aviv, Israel0
1375 W Fulton Ave, Chicago, IL 60607, US Suite 650, United States
121 Menachem Begin, 59th floor, Tel Aviv, Israel0
Investors
Vertex Ventures
Vertex Ventures
Grove Ventures
Grove Ventures
Fosun RZ Capital
Fosun RZ Capital
Section 32 (venture capital firm)
Section 32 (venture capital firm)
Sanofi Ventures
Sanofi Ventures
Founded Date
2018
0
Total Funding Amount (USD)
33,000,000
Latest Funding Round Date
March 23, 2022
CTO
‌
Albert Achtenberg
0
Latest Funding Type
Series B
Series B
COO
Eliron Amir
Eliron Amir
0
Country
United States
United States
0
Israel
Israel
0

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
33,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Nucleai

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.